$97.96
3.84% yesterday
NYSE, Apr 04, 10:10 pm CET
ISIN
US29261A1007
Symbol
EHC

Encompass Health Corporation Stock price

$97.96
-0.49 0.50% 1M
+3.46 3.66% 6M
+5.61 6.07% YTD
+16.96 20.94% 1Y
+41.78 74.36% 3Y
+47.10 92.60% 5Y
+62.41 175.57% 10Y
NYSE, Closing price Fri, Apr 04 2025
-3.91 3.84%
ISIN
US29261A1007
Symbol
EHC
Sector

Key metrics

Market capitalization $9.89b
Enterprise Value $13.22b
P/E (TTM) P/E ratio 21.96
EV/FCF (TTM) EV/FCF 36.70
EV/Sales (TTM) EV/Sales 2.46
P/S ratio (TTM) P/S ratio 1.84
P/B ratio (TTM) P/B ratio 4.78
Dividend yield 0.48%
Last dividend (FY24) $0.47
Revenue growth (TTM) Revenue growth 11.91%
Revenue (TTM) Revenue $5.37b
EBIT (operating result TTM) EBIT $864.50m
Free Cash Flow (TTM) Free Cash Flow $360.30m
Cash position $162.10m
EPS (TTM) EPS $4.46
P/E forward 19.58
P/S forward 1.69
EV/Sales forward 2.26
Short interest 2.32%
Show more

Is Encompass Health Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Encompass Health Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Encompass Health Corporation forecast:

13x Buy
93%
1x Hold
7%

Analyst Opinions

14 Analysts have issued a Encompass Health Corporation forecast:

Buy
93%
Hold
7%

Financial data from Encompass Health Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
5,373 5,373
12% 12%
100%
- Direct Costs 4,300 4,300
11% 11%
80%
1,074 1,074
15% 15%
20%
- Selling and Administrative Expenses - -
- Research and Development Expense - -
-
-
1,164 1,164
16% 16%
22%
- Depreciation and Amortization 300 300
9% 9%
6%
EBIT (Operating Income) EBIT 865 865
18% 18%
16%
Net Profit 453 453
29% 29%
8%

In millions USD.

Don't miss a Thing! We will send you all news about Encompass Health Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Encompass Health Corporation Stock News

Neutral
PRNewsWire
18 days ago
The 40-bed inpatient rehabilitation hospital is a joint venture between Encompass Health and Piedmont. BIRMINGHAM, Ala.
Positive
Investors Business Daily
26 days ago
Physical therapy stock Encompass Health is in a base awaiting a catalyst for its next move. The company's profit grew 23% in the fourth quarter.
Neutral
PRNewsWire
about one month ago
BIRMINGHAM, Ala. , Feb. 26, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE: EHC) today announced it will participate in the Barclays Global Healthcare Conference, which is being held March 11-13, 2025.
More Encompass Health Corporation News

Company Profile

Encompass Health Corp. engages in providing post-acute healthcare services. It operates through the following segments: Inpatient Rehabilitation and Home Health & Hospice. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provides rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac & pulmonary conditions, brain & spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.

Head office United States
CEO Mark Tarr
Employees 40,000
Founded 1984
Website www.encompasshealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today